Confidential Treatment requested.
Confidential portions of this document have been
redacted and have been filed separately
with the Commission
TO DISTRIBUTION AGREEMENT
THIS FIRST AMENDMENT is made by and between MEDICAL COMPONENTS, INC. (hereinafter referred to as
“MEDCOMP”), a corporation organized and existing under the laws of the Commonwealth of Pennsylvania, United States of
America, having its principal office at 1499 Delp Drive, Harleysville, Pennsylvania, 19438, and ANGIODYNAMICS, INC. , a
corporation organized and existing under the laws of the State of Delaware, United States of America, having its principal office
at 603 Queensbury Avenue, Queensbury, New York 12804 (hereinafter referred to as “ANGIODYNAMICS”).
WHEREAS, MEDCOMP and ANGIODYNAMICS entered into a Distribution Agreement dated June 22, 2004 (hereinafter
referred to as “the Distribution Agreement”), under which ANGIODYNAMICS distributes certain medical devices and products
produced by MEDCOMP;
AND WHEREAS, MEDCOMP and ANGIODYNAMICS desire to amend certain aspects of the Distribution Agreement in
accordance with this First Amendment;
NOW, THEREFORE, in consideration of the mutual covenants contained herein, the parties agree as follows:
Effective Date . This First Amendment shall be effective as of November 4, 2005.
Exhibits . Exhibits A through F of the Distribution Agreement are hereby replaced with the Exhibits A through H
3. Amendments .
Paragraph 1.2 is hereby amended and restated to read as follows:
“Products” as used herein shall mean those products as set forth in Exhibits A, B, C, D, E, F, G, and H
(“hereinafter Exhibits A-H”) attached hereto. Exhibits A-H may be modified from time to time, during the
effective period of this Agreement, by the mutual written consent of the parties.
All references to “Exhibits A-E” throughout the Distribution Agreement are amended and